Ningbo Menovo Pharmaceutical Co Ltd Class A 603538
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥11.03
- Day Range
- ¥11.12–11.56
- 52-Week Range
- ¥9.96–22.02
- Bid/Ask
- ¥11.52 / ¥11.53
- Market Cap
- ¥2.52 Bil
- Volume/Avg
- 3.0 Mil / 2.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 30.88
- Price/Sales
- 2.06
- Dividend Yield (Trailing)
- 0.18%
- Dividend Yield (Forward)
- 0.18%
- Total Yield
- 0.18%
Company Profile
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,353
- Website
- http://www.menovopharm.com
Comparables
Valuation
|
Metric
|
603538
|
300194
|
002864
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.88 | 16.41 | 23.40 |
Price/Book Value | 1.14 | 1.12 | 1.66 |
Price/Sales | 2.06 | 1.84 | 2.71 |
Price/Cash Flow | — | 10.63 | 15.94 |
Price/Earnings
603538
300194
002864
Financial Strength
|
Metric
|
603538
|
300194
|
002864
|
|---|---|---|---|
Quick Ratio | 0.73 | 0.99 | 3.66 |
Current Ratio | 1.24 | 1.59 | 3.89 |
Interest Coverage | 0.70 | 12.64 | 27.93 |
Quick Ratio
603538
300194
002864
Profitability
|
Metric
|
603538
|
300194
|
002864
|
|---|---|---|---|
Return on Assets (Normalized) | 0.05% | 1.26% | 5.20% |
Return on Equity (Normalized) | 0.11% | 1.84% | 7.55% |
Return on Invested Capital (Normalized) | 0.48% | 1.44% | 5.71% |
Return on Assets
603538
300194
002864
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Dggbxwmb | Ygdc | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Gyphzvhf | Lpxgk | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Dnmswhzcv | Xmj | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Bsflgqmn | Sgrm | $19.0 Bil | |||
| Viatris Inc
VTRS
| Dqwgnfg | Wcbc | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Gmpmrvr | Tfs | $13.4 Bil | |||
| Catalent Inc
CTLT
| Bbvnnmxn | Mltjnky | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Dpvxgksc | Bgrjmm | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Ywwcvryj | Pryy | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dzrbcwnq | Mpvn | $2.5 Bil |
United States